SINOPHARM GROUP CO., LTD. Inactive Instrument
Sinopharm Group Co., Ltd. Share Price Shanghai - Hong Kong Stock Connect
Equities
1099
CNE100000FN7
Pharmaceuticals
| Sales 2024 * | 647B 89.03B 695B 7,049B | Sales 2025 * | 704B 96.9B 757B 7,672B | Capitalization | 60.26B 8.29B 64.75B 657B |
|---|---|---|---|---|---|
| Net income 2024 * | 9.64B 1.33B 10.36B 105B | Net income 2025 * | 10.6B 1.46B 11.38B 115B | EV / Sales 2024 * | 0.11 x |
| Net Debt 2024 * | 10.04B 1.38B 10.79B 109B | Net Debt 2025 * | 5.72B 788M 6.15B 62.36B | EV / Sales 2025 * | 0.09 x |
| P/E ratio 2024 * |
6.24
x | P/E ratio 2025 * |
5.69
x | Employees | - |
| Yield 2024 * |
4.84% | Yield 2025 * |
5.32% | Free-Float | 42.99% |
More Fundamentals
* Assessed data
More news
More recommendations
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Liu
PSD | President | 55 | 08/01/09 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 28/02/11 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 30/04/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 30/04/10 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 10/01/19 |
Yi Jian Wu
SEC | Corporate Secretary | 54 | - |
Sinopharm Group Co. Ltd. specialises in the distribution of pharmaceutical products and medical devices to hospitals, clinics, pharmacies and third-party distributors. The group also operates pharmacy chains. Net sales break down by activity as follows:
- distribution of pharmaceutical products (71%) ;
- distribution of medical devices (21.7%);
- operation of directly-owned and franchised pharmacy chains (5.9%);
- other (1.4%).
Sector
Pharmaceuticals
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| -2.46% | 23.95B | |
| +14.23% | 8.7B | |
| -32.92% | 6.7B | |
| +18.62% | 5.38B | |
| +1.10% | 4.08B | |
| -9.24% | 3.79B | |
| -10.20% | 3.3B | |
| +7.58% | 3.2B | |
| +7.11% | 3.19B |
